Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Ureteral Stents market is influenced by several key factors that collectively shape its dynamics and growth trajectory. One significant factor is the increasing prevalence of urological disorders and conditions, such as kidney stones and urinary obstructions, which drive the demand for ureteral stents. These small, flexible tubes play a critical role in maintaining patency of the ureter, relieving obstructions, and allowing urine to flow from kidneys into the bladder.
Besides, another thing that has contributed to a boom in Ureteral Stents market is an ageing population. As one ages, they are more prone to developing urological issues or complications that might require the use of ureteral stents. This demographic shift towards older age demography particularly in developed regions underscores the significance of urological interventions while driving up the demand for these medical devices.
Furthermore, there has been an upward trend on global kidney stone incidences as a major market driver. They facilitate easy passage of stones thereby providing relief as well as preventing possible complications. Timely intervention importance on cases of kidney stones has also led to increased adoption rates for ureteral stent use.
Additionally, hospital acquired infections are a challenge within healthcare sector also in Ureteral Stents market. The current trend is shifting towards development of antimicrobial coated stents addressing infection related complications due to prolonged placement of these devices within patients’ bodies. This goes hand in hand with broader healthcare focus on reducing HAIs incidence rates to enhance patient outcomes.
Moreover, there are rising number instances whereby outpatient procedures have become more common among various urological interventions affecting Ureteral Stents market. Some factors that have resulted into this include shorter hospital stays, faster recovery times and lower health costs associated with such procedures like placing ureteral stents. As such worldwide health systems continue emphasizing more about outpatient care; ureteral stent industry adjusts to fit these preferences.
Moreover, healthcare reforms and initiatives play a part in determining the Ureteral Stents market landscape. The growth of the market is enhanced by policies aimed at improving patient access to urological interventions and strengthening healthcare infrastructure. For instance, such schemes ensure that patients with urological disorders are treated on time by making sure they have access to ureter stenting facilities.
Also, Ureteral Stents market is affected by competition and key industry players. These have resulted into ongoing researches, development programs that are strategic, collaborations as well as mergers and acquisitions which affect the market dynamics in general. Competitive landscape drives innovation of products as well as new technologies introduction thus benefiting both healthcare providers and patients.
In addition, patient preferences and comfort are taken into account increasingly during the design of ureteral stents. Some of these innovations include coatings for the prevention of encrustation, smoother surfaces for reducing discomforts or user friendly designs leading to improved user experience. This enables acceptance as well compliance of patients with ureteral stent placement thereby enhancing quality life for those undergoing various urological interventions; hence growing this market.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Market Size Value In 2022 | USD 0.48 Billion |
| Market Size Value In 2023 | USD 0.50 Billion |
| Growth Rate | 5.7% (2023-2032) |
Ureteral Stents Market Highlights:
Global Ureteral Stents Market Overview
Ureteral Stents Market Size was valued at USD 0.48 billion in 2022. The ureteral stents market industry is projected to grow from USD 0.50 Billion in 2023 to USD 0.5 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.7% during the forecast period (2023 - 2032).Growing incidence of kidney diseases, rising burden of urological disorders and rising product approvals by regulatory authorities are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Ureteral Stents Market Trends
- Growing incidence of kidney diseases to boost market growth
The growing incidence of kidney diseases has a significant impact on the ureteral stents market. Kidney diseases such as kidney stones, urinary tract infections, tumors, and other urological disorders often require the placement of a ureteral stent. A ureteral stent is a flexible, hollow tube that is inserted into the ureter to help urine flow from the kidney to the bladder. Ureteral stents are used to treat a variety of conditions, including kidney stones, tumors, and strictures. The increasing prevalence of kidney diseases, particularly kidney stones, is one of the key drivers of the ureteral stents market. According to a report by the National Kidney Foundation, kidney stones affect about one in ten people at some point in their lives, and the incidence of kidney stones has been increasing over the past few decades. In addition, the increasing aging population is also contributing to the growth of the ureteral stents market. As people age, they are more likely to develop urological disorders that require the use of ureteral stents. Moreover, technological advancements in ureteral stent design and materials have also driven the growth of the ureteral stents market CAGR. These advancements have led to the development of stents with improved durability, biocompatibility, and ease of insertion, which has made them more attractive to both patients and healthcare providers.
Rising prevalence of kidney diseases is projected to propel worldwide ureteral stents market to expand during the projection period. For instance, the United States Renal Data System (USRDS) reports that there are around 786,000 people in the country who have end-stage renal disease (ESRD), of whom 71% require dialysis and 29% a kidney transplant. In the United States, 131,636 people have received an ESRD diagnosis in 2018, a 2.3% increase from 2017. Unadjusted ESRD incidence per million grew by 1.5% between 2017 and 2018, however adjusted ESRD incidence per million increased by just 0.2%. Also, According to USRDS Coordinating Center (CC), 14.9% of the adult population in the United States that were surveyed during 2015 and 2018 had chronic kidney disease (CKD) based on a low eGFR or proteinuria (on a single examination). According to the same organization, in 2018, the number of End-Stage Renal Disease (ESDR) incidents reported were 1,31,112 and in 2019, the number reached 1,34,608. which is anticipated to fuel significant growth of ureteral stents market revenue.
Ureteral Stents Market Segment Insights
Ureteral Stents Type Insights
The ureteral stents market segmentation, based on type, includes Double Pigtail Ureteral Stent, Others. The double pigtail ureteral stent segment held the majority share in 2022 contribution to significant share in respect to the ureteral stents market revenue. This is primarily owing to growth in urological diseases and obstruction, a strong demand for stents with minimal migration, and basis of growth of cutting-edge stents with few disadvantages. Also, a number of actions done by the government and healthcare organizations also contribute to the market's expansion.
Ureteral Stents Material Insights
The ureteral stents market segmentation, based on material, includes metallic stents, polymers stents, others. The metallic stents segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. This is due to the metallic ureteral stents' resistance toward being encrusted with stone material. As a result, stent change procedures are performed less frequently and dwelling durations are extended. Also, using a metallic ureteral stent for benign ureteral obstruction results in lower overall procedural costs than using a polymer stent. Hence, rising demand of metal material implants for ureteral stents positively impacts the market growth.
Ureteral Stents Treatment Insights
The ureteral stents market data has been bifurcated by treatment into Kidney Stones, Kidney Transplant, Others. The kidney stones segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. The adoption of a sedentary lifestyle and dietary trends that cause urolithiasis are two factors that are fueling the expansion of this market segment. For instance, a 2018 study published in the NCBI predicted that over 600,000 Americans get urinary stones each year. The need for ureteral stent during ureteroscopy and ureterorenoscopy, among other operations used to treat kidney stones, is what is causing the segment to grow.
Figure 1: Ureteral Stents Market, by Treatment, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Ureteral Stents End User Insights
Based on End Users, the ureteral stents industry has been segmented into hospitals, nephrological centers, ambulatory surgical centers. Multispecialty hospitals held the largest segment share in 2022, due to the geriatric population's preference for hospital treatments, as all related treatments are carried out under one roof. In addition, hospitals perform a greater number of surgical procedures and rising government investment in hospital sector is anticipated to support the market growth.
Ureteral Stents Regional Insights
By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Ureteral Stents market accounted for USD 0.22 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. This is attributed to the growing presence of Key market players like Boston Scientific Company, Medline Industries, and Coloplast are present and helping to drive expansion in the area. In addition, raising government healthcare spending opens up new business opportunities.
Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: URETERAL STENTS MARKET SHARE BY REGION 2022 (%)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe ureteral stents market accounts for the second-largest market share due to the availability of cutting-edge treatment facilities, growing prevalence of chronic kidney disease, rising aging population, and growing government investment in healthcare development. Further, the Germany ureteral stents market held the largest market share, and the UK ureteral stents market was the fastest growing market in the European region
The Asia-Pacific Ureteral Stents Market is expected to grow at the fastest CAGR from 2022 to 2030. This is due to increased rates of osteoarthritis and degenerative disc disease, the rapidly growing medical tourism industry, and rising healthcare costs. Moreover, China ureteral stents market held the largest market share, and the India ureteral stents market was the fastest growing market in the Asia-Pacific region.
Ureteral Stents Key Market Players & Competitive Insights
Major market players are spending a lot of money on R&D to increase their product lines, which will help the ureteral stents market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the ureteral stents industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies adopted by manufacturers in the ureteral stents industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, ureteral stents industry has provided treatment with some of the most significant benefits. The ureteral stents market major player such as Boston Scientific (US), Cook Medical (US), Allium Medical (Israel), and others are working to expand the market demand by investing in research and development activities.
The Boston Scientific Corporation was established in year 1979 and its headquarters is in Marlborough, Massachusetts, United States. The company is a medical device developer, producer, and marketer with products used in a variety of interventional medical specialties. Cardiovascular and cardiac rhythm management (CRM) products are the company's key products. Electrophysiology, pain treatment (neuromodulation), endoscopy, pelvic health, and urology are among the devices it produces. Biopsy forceps, coronary and urethral stents, catheters, defibrillators, pacemakers and needles are some of the company's diagnostic and treatment products. The company globally provides its products and services in more than 120 countries. The employee size of the company is 10,001+ employees. In June 2022, for its Tria Ureteral Stent, the first stent built with a patented surface technology intended to give protection against the accumulation from both urine calcium and magnesium salt deposits, Boston Scientific has been honoured with a Bronze Edison Award in the field of Science and Medicine.
Also, Allium Medical was established in year 2008 and its headquarters is in Haeshel St, Caesarea, Israel. The company develops, produces, and markets cutting-edge, long-lasting, fully covered, expandable, and retrievable stents for the treatment of various blockages in the GI and urinary tracts on a scale. In contrast to the usual practise of surgery or short-term solutions, Allium's distinctive stent solutions offer a less invasive, reversible alternative approach. With its extensive proven experience and usage, Allium is paving the way for patients and doctors to provide the next level of patient care. In May 2018, The China Food and Drug Administration (CFDA) has granted Allium Medical, an Israeli medical device firm that specialises in minimally invasive technologies and solutions, permission to commercialise its range of urology systems in China. In the Chinese urology sector, the company has an exclusive strategic partnership with a distribution company.
Key Companies in the ureteral stents market includes
-
Boston Scientific (US)
-
Cook Medical (US)
-
C.R. Bard (US)
-
B. BRAUN (Germany)
-
Olympus (Japan)
-
Coloplast (Denmark)
-
Allium Medical (Israel)
-
Teleflex Incorporated (US)
-
Biomerics (Italy)
-
Medline industries inc. (US), among others
Ureteral Stents Industry Developments
May 2022:The United States Food and Drug Administration approved 510k clearance for a new urinary stent generated by Dean Secrest and Lee Ponsky, MD, the Chair of the Department of Urology and Leo and Charlotte Goldberg, Chair in Advanced Surgeons Therapies at University Hospitals (UH) in Cleveland.April 2019:The Stone Management Ureteral Stent and the Axis single-use digital flexible ureter scope are new products from Dornier Med Tech. This stent will aid in lowering cross-contamination among patients in the same operating room by giving a clean and sterile ureteroscope for each single use.
Ureteral Stents Market Segmentation
Ureteral Stents Type Outlook
-
Double Pigtail Ureteral Stent
-
Others
Ureteral Stents Material Outlook
-
Metallic Stents
-
Polymers Stents
-
others
Ureteral Stents Treatment Outlook
-
-
Kidney Transplant
-
Others
Ureteral Stents End User Outlook
-
Hospitals
-
Nephrological Centers
-
Ambulatory Surgical Centers
Ureteral Stents Regional Outlook
-
North America
-
US
-
Canada
-
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Rest of Europe
-
Asia-Pacific
-
China
-
Japan
-
India
-
Australia
-
South Korea
-
Australia
-
Rest of Asia-Pacific
-
-
Rest of the World
-
Middle East
-
Africa
-
Latin America
-
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
